Affordable Access

Publisher Website

Evolution of β-Cell Replacement Therapy in Diabetes Mellitus: Islet Cell Transplantation

Journal of Transplantation
Hindawi Publishing Corporation
Publication Date
DOI: 10.1155/2011/247959
  • Review Article
  • Medicine


Diabetes mellitus remains one of the leading causes of morbidity and mortality worldwide. According to the Centers for Disease Control and Prevention, approximately 23.6 million people in the United States are affected. Of these individuals, 5 to 10% have been diagnosed with Type 1 diabetes mellitus (T1DM), an autoimmune disease. Although it often appears in childhood, T1DM may manifest at any age, leading to significant morbidity and decreased quality of life. Since the 1960s, the surgical treatment for diabetes mellitus has evolved to become a viable alternative to insulin administration, beginning with pancreatic transplantation. While islet cell transplantation has emerged as another potential alternative, its role in the treatment of T1DM remains to be solidified as research continues to establish it as a truly viable alternative for achieving insulin independence. In this paper, the historical evolution, procurement, current status, benefits, risks, and ongoing research of islet cell transplantation are explored.

There are no comments yet on this publication. Be the first to share your thoughts.


Seen <100 times

More articles like this

Evolution of β-Cell Replacement Therapy in Diabete...

on Diabetes technology & therapeu... March 2011

Beta-cell replacement therapy (pancreas and islet...

on Transplantation Proceedings 2004

Current status of beta-cell replacement therapy (p...

on Transplantation Proceedings August 2003

Beta-cell replacement therapy (pancreas and islet...

on Endocrinology and metabolism c... March 2004
More articles like this..